Dr. Smitha Mellacheruvu, MD
- Medicare services, 2024
- 976
- Medicare patients, 2024
- 157
- Part D claims, 2024
- 275
- MIPS score, 2024
- 99
- Hospital affiliations
- 6
- Practice address
- 400 East Main Street, Mount Kisco, NY 10549
- Practice phone
- Call (914) 666-1200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Mellacheruvu's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Smitha Mellacheruvu is a hematologist and oncologist in Mount Kisco, New York
Dr. Mellacheruvu practices at Northern Westchester Hospital in Mount Kisco, New York, part of Northwell Health.
Dr. Mellacheruvu's NPI, 1548330970, was assigned on November 9, 2006. Dr. Mellacheruvu holds New York license 0229985.
- NPI
- 1548330970NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6800896531
- NPI enumeration date
- November 9, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (914) 666-1200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 53
- Medical school graduation
- 1999
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Smitha Mellacheruvu practices at Northern Westchester Hospital in Mount Kisco, New York
Dr. Mellacheruvu's primary practice is Northern Westchester Hospital, at 400 East Main Street, Mount Kisco, NY 10549 in Westchester County. The practice phone is (914) 666-1200.
- Northern Westchester Hospital400 East Main Street, Mount Kisco, NY 10549 · Westchester CountyPhone(914) 666-1200
Source: Dmand AI Affiliation Data
Dr. Smitha Mellacheruvu is affiliated with 6 sites of care and 3 medical groups
Dr. Mellacheruvu's primary practice is Northern Westchester Hospital in Mount Kisco, New York, part of Northwell Health. Dr. Mellacheruvu is also affiliated with Montefiore Einstein Hospital-Moses Campus. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Mellacheruvu to 4 more hospitals and 2 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Smitha Mellacheruvu's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mellacheruvu practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Northern Westchester Hospital | Available with a free account |
| +5 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Northwell Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Smitha Mellacheruvu is one of 996 hematologists and oncologists in New York
Hematology and oncology is Dr. Mellacheruvu's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mellacheruvu is licensed in New York.
Specialties and state licenses
- Hematology and oncology, New YorkPrimary
Hematologists and oncologists near Dr. Mellacheruvu
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Smitha Mellacheruvu billed Medicare for 976 services in 2024
CMS data shows 976 Medicare services from Dr. Mellacheruvu across 22 procedure codes in 2024, for 157 Medicare patients. Medicare paid $32,234 for them.
Dr. Mellacheruvu's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Lab and pathology
- 2023: 02024: 521
- Office and hospital visits
- 2023: 1,4162024: 21685%
- Surgery
- 2023: 7422024: 15479%
- Tests and treatments
- 2023: 02024: 85
Where Dr. Mellacheruvu's Medicare services took place, 2024
- In an office94797%
- In a facility293%
Dr. Mellacheruvu compared with the New York median for hematologists and oncologists, 2024
- Dr. Mellacheruvu
- New York median
- Medicare services
- 976vs 66846% above
- Medicare patients
- 157vs 21025% below
- Part D claims
- 111vs 25857% below
Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.
Dr. Mellacheruvu's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Mellacheruvu?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mellacheruvu and other hematologists and oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Smitha Mellacheruvu treated 157 Medicare patients in 2024, average age 74
CMS counts 157 Medicare patients who saw Dr. Mellacheruvu in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Mellacheruvu's median patient age at 68, with 53% women.
Dr. Mellacheruvu's Medicare patients by age, 2024
Dr. Mellacheruvu's Medicare patients by sex, 2024
- Women9057%
- Men6743%
Chronic conditions among Dr. Mellacheruvu's Medicare patients, 2024
- High blood pressure75%
- High cholesterol73%
- Arthritis45%
- Cancer39%
- Ischemic heart disease38%
- Anxiety34%
- Mood disorders34%
- COPD31%
Share of Medicare patients with each condition. A patient can have several.
Dr. Mellacheruvu's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women53%
- Men45%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Smitha Mellacheruvu wrote 275 Medicare Part D claims in 2024
In 2024, Dr. Mellacheruvu wrote 275 Medicare Part D claims for 93 patients. 83% of them were for generic drugs. CMS names the drug for 111 of them, across 6 drugs with 11 or more claims each, at $17,389 in total drug cost. In 2023, CMS named 510 claims across 19 drugs.
Dr. Mellacheruvu's Part D claims by kind of drug, 2024
- Generic229 claims83%
- Brand-name46 claims17%
Dr. Mellacheruvu's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5102024: 11178%
Drugs named by CMS: 6 in 2024, 19 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Smitha Mellacheruvu scored 99 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Mellacheruvu for performance year 2024, reported as part of a group. Dr. Mellacheruvu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mellacheruvu as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Mellacheruvu's MIPS scores, performance year 2024
- 99of 100Final score
- 40of 100Improvement Activities
- 82of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Smitha Mellacheruvu received $1,471 in industry payments from 2016 to 2025
CMS Open Payments shows 60 general payments to Dr. Mellacheruvu from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Pfizer Inc. paid the most, $250.
General payments to Dr. Mellacheruvu by program year, 2016 to 2025
General payments to Dr. Mellacheruvu by kind, 2016 to 2025
- Food and beverage$1,17480%
- Education$29820%
Companies that paid Dr. Mellacheruvu the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Smitha Mellacheruvu's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Smitha Mellacheruvu
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Smitha Mellacheruvu's NPI number?
Dr. Smitha Mellacheruvu's NPI number is 1548330970. It was assigned on November 9, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Smitha Mellacheruvu?
Dr. Smitha Mellacheruvu is a hematologist and oncologist in Mount Kisco, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Smitha Mellacheruvu practice?
Dr. Mellacheruvu practices at 400 East Main Street, Mount Kisco, NY 10549. Dr. Mellacheruvu's primary practice is Northern Westchester Hospital in Mount Kisco, New York, part of Northwell Health. Dmand AI also links Dr. Mellacheruvu to 4 hospitals and 2 medical groups.
What is Dr. Smitha Mellacheruvu's office phone number?
The practice phone on file for Dr. Mellacheruvu is (914) 666-1200.
What is Dr. Smitha Mellacheruvu's medical license number?
Dr. Mellacheruvu holds New York license 0229985.
Which hospitals is Dr. Smitha Mellacheruvu affiliated with?
Dr. Mellacheruvu practices at Northern Westchester Hospital in Mount Kisco, New York. Dr. Mellacheruvu is also affiliated with Montefiore Einstein Hospital-Moses Campus. Dmand AI links Dr. Mellacheruvu to 4 more hospitals.
What medical group is Dr. Smitha Mellacheruvu part of?
Dr. Mellacheruvu is linked to Montefiore Einstein Faculty Practice Group. Dmand AI links Dr. Mellacheruvu to 2 more medical groups.
Does Dr. Smitha Mellacheruvu accept Medicare?
Yes. CMS data shows Dr. Mellacheruvu billed Medicare for 976 services in 2024, and Dr. Mellacheruvu accepts Medicare assignment.
Does Dr. Smitha Mellacheruvu offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Mellacheruvu as offering telehealth services.
What is Dr. Smitha Mellacheruvu's MIPS score?
Dr. Mellacheruvu's MIPS final score for performance year 2024 is 99 out of 100, reported as part of a group.
Show 5 more questionsShow fewer questions
How many Medicare patients does Dr. Smitha Mellacheruvu see?
CMS counts 157 Medicare patients who saw Dr. Mellacheruvu in 2024, with an average age of 74.
What services does Dr. Smitha Mellacheruvu bill to Medicare?
In 2024, Dr. Mellacheruvu's most billed Medicare services were surgery: heart and blood vessels (36415), lab and pathology test (85025) and lab and pathology test (80053).
What drugs does Dr. Smitha Mellacheruvu prescribe most?
In 2024 Medicare Part D data, Dr. Mellacheruvu's most prescribed drugs by claims were Pantoprazole Sodium, Eliquis and Anastrozole.
Has Dr. Smitha Mellacheruvu received payments from drug or device companies?
CMS Open Payments shows $1,471 in general payments to Dr. Mellacheruvu from 24 companies from 2016 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Smitha Mellacheruvu been practicing?
Dr. Mellacheruvu graduated from medical school in 1999, 27 years ago.
Selling to hematology and oncology practices?
See hematologists and oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card